High-Intensity Interval Training, Inflammatory Biomarkers, and Circulating MicroRNAs in Human Clinical Obesity.
Effects of High-Intensity Interval Training on Body Composition, Inflammatory Biomarkers, and Circulating MyomiRs in Adults With Clinical Obesity: A Randomized Controlled Trial.
This randomized controlled trial evaluates the effects of high-intensity interval training (HIIT) on body composition, inflammatory biomarkers, and circulating microRNAs in adults with clinical obesity. Circulating microRNAs are small regulatory molecules that may reflect exercise-induced adaptations and inter-tissue communication related to skeletal muscle and metabolic health. The study investigates whether exercise-induced changes in adiposity are accompanied by changes in inflammatory status and circulating microRNA profiles associated with skeletal muscle adaptations and metabolic health.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
Clinical obesity is characterized by excessive adiposity accompanied by impaired metabolic health and chronic low-grade inflammation. Emerging evidence suggests that obesity is also associated with alterations in circulating molecular biomarkers that may influence skeletal muscle function and inter-tissue communication.
High-intensity interval training (HIIT) is an effective exercise strategy for improving body composition and cardiometabolic health; however, the molecular mechanisms underlying these adaptations remain incompletely understood. In particular, limited information is available regarding the response of circulating muscle-related microRNAs (myomiRs) to exercise interventions in adults with clinical obesity.
This randomized controlled trial is designed to investigate physiological and molecular adaptations to HIIT in adults with clinical obesity. The study will examine the relationship between changes in adiposity, systemic inflammation, and circulating microRNA expression following a supervised exercise intervention. Circulating microRNAs may provide insight into exercise-responsive biological pathways and represent potential biomarkers of skeletal muscle adaptation and metabolic health.
The findings may improve understanding of the molecular mechanisms associated with exercise-induced health benefits in clinical obesity and contribute to the identification of novel biomarkers relevant to obesity management and precision exercise medicine.
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Sofia Uribe-Cerda, MSc.
- Telefonnummer: +56 975396081
- E-post: s.uribecerda@uandresbello.edu
Studer Kontakt Backup
- Navn: Mayalen Valero Breton, PhD.
- Telefonnummer: +56 992204392
- E-post: mayalen.valero@unab.cl
Studiesteder
-
-
Metropolitan Region
-
Santiago, Metropolitan Region, Chile
- Exercise and Rehabilitation Sciences Institute, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andres Bello.
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adults aged 20 to 39 years.
- Clinical obesity defined primarily by body fat percentage (>29% in women and >20% in men), complemented by body mass index (BMI ≥30 kg/m²) and waist-to-height ratio (≥0.55).
- Low habitual physical activity level, defined as not meeting the criteria for moderate or high physical activity according to the International Physical Activity Questionnaire-Short Form (IPAQ-SF).
Exclusion Criteria:
- Cardiovascular disease.
- Metabolic disease (e.g., type 2 diabetes mellitus or dyslipidemia).
- Inflammatory or autoimmune disease (e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, or psoriasis).
- Current smoking.
- Chronic medication use that may affect metabolic or inflammatory outcomes.
- Pregnancy and lactation.
- Participation in a structured exercise program within the previous 6 months. Contraindications to high-intensity exercise.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: High-Intensity Interval Training (HIIT)
Participants assigned to this arm will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during 8 weeks. Each training session will last approximately 30 minutes and include a warm-up, high-intensity intervals performed at approximately 90% of maximal power output, active recovery periods, and a cool-down. All sessions will be supervised by qualified personnel to ensure participant safety and adherence to the protocol. |
Participants will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during eight weeks. Each session will last approximately 30 minutes and consist of a warm-up, ten 1-minute high-intensity intervals performed at approximately 90% of maximal power output, interspersed with 1-minute active recovery periods, and a cool-down. Training intensity will be reassessed midway through the intervention to ensure appropriate progression. All sessions will be supervised by qualified personnel to promote adherence, proper exercise execution, and participant safety. |
|
Ingen inngripen: Control
Participants assigned to this arm will maintain their habitual lifestyle without participating in a structured exercise program during the intervention period. Educational materials on healthy lifestyle habits will be provided at the end of the study. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Total Body Fat Mass Assessed by Bioelectrical Impedance Analysis
Tidsramme: Change from baseline to Week 8
|
Total body fat mass (kg) will be assessed using bioelectrical impedance analysis and compared between baseline and post-intervention measurements. |
Change from baseline to Week 8
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Plasma Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) concentration Assessed by ELISA
Tidsramme: From baseline to Week 8
|
Plasma IL-1β concentration (pg/mL) and TNF-α concentration (pg/mL) measured by enzyme-linked immunosorbent assay (ELISA). |
From baseline to Week 8
|
|
Circulating Myo-MicroRNAs
Tidsramme: from enrollment to the end of treatment at 8 weeks
|
Change in circulating expression of miR-1, miR-133, and miR-206 quantified by RT-qPCR. |
from enrollment to the end of treatment at 8 weeks
|
|
Peak Oxygen Uptake (VO₂peak)
Tidsramme: From baseline to Week 8
|
Change in cardiorespiratory fitness assessed by peak oxygen uptake during an incremental cycling test. |
From baseline to Week 8
|
|
Handgrip Strength
Tidsramme: From baseline to Week 8
|
Change in maximal handgrip strength assessed using a hydraulic hand dynamometer. |
From baseline to Week 8
|
|
Maximal Voluntary Isometric Contraction (MVC)
Tidsramme: From baseline to Week 8
|
Change in maximal isometric strength of the knee extensor muscles measured by dynamometry. |
From baseline to Week 8
|
|
Health-Related Quality of Life Assessed Using the 36-Item Short Form Health Survey (SF-36)
Tidsramme: From baseline to Week 8
|
Change in health-related quality of life assessed using the 36-Item Short Form Health Survey (SF-36). Scores range from 0 to 100, with higher scores indicating better perceived health status and quality of life. |
From baseline to Week 8
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- 64B2025
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .